Search

Author/Creator Pavilack, Melissa

1. EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer. (2021)

Authors:
Hung, Anna; Lee, Kyung Min; Alba, Patrick R.; Li, Yanhong; Gao, Anthony Z.; Hintze, Bradley J.; Efimova, Olga V.; Shenolikar, Rahul; Pavilack, Melissa; Simmons, Dan; Kelley, Michael J.; Lynch, Julie A.; Reed, Shelby D.
Journal:
Cancer treatment and research communications
Issue:
Number 27(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Real-world impact of brain metastases on healthcare utilization and costs in patients with non-small cell lung cancer treated with EGFR-TKIs in the US. (1st January 2021)

Authors:
Kong, Amanda M.; Pavilack, Melissa; Huo, Hairong; Shenolikar, Rahul; Moynihan, Meghan; Marchlewicz, Elizabeth H.; Chebili-Larson, Christina; Min, Stella; Subramaniam, Deepa S.
Journal:
Journal of medical economics
Issue:
Volume 24:Number 1(2021)
Page Start:
328
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. The rate of occurrence, healthcare resource use and costs of adverse events among metastatic non-small cell lung cancer patients treated with first- and second-generation epidermal growth factor receptor tyrosine kinase inhibitors. (December 2019)

Authors:
Subramanian, Janakiraman; Fernandes, Ancilla W.; Laliberté, François; Pavilack, Melissa; DerSarkissian, Maral; Duh, Mei Sheng
Journal:
Lung cancer
Issue:
Volume 138(2019)
Page Start:
131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗